Thermo Fisher Scientific Analytical Instruments — Consolidated revenues increased by 4.7% to $1.89B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.7%, from $1.81B to $1.89B. This is a positive signal — higher values indicate stronger performance for this metric.
Increasing revenue signals strong market adoption and effective sales execution; decreasing revenue may signal market saturation or competitive pressure.
The total gross income generated by the Analytical Instruments segment from the sale of scientific instruments and relat...
Directly comparable to revenue segments in other laboratory equipment and life science tool manufacturers.
tmo_segment_analytical_instruments_consolidated_revenues| Q2 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $1.48B | $1.52B | $1.61B | $1.82B | $1.82B | $1.82B | $1.82B | $1.81B | $1.89B |
| QoQ Change | — | +2.5% | +5.9% | +13.0% | +0.0% | +0.0% | +0.0% | -0.4% | +4.7% |
| YoY Change | — | — | +8.5% | +19.6% | +13.0% | — | — | -0.4% | +4.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.